Evidence map›Paper›PMID 26914104›Full record

Trial reportQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2016

Xerostomia health-related quality of life: NRG oncology RTOG 0537.

Gwen Wyatt, Stephanie L Pugh, Raimond K W Wong, Stephen Sagar, Anurag K Singh, Shlomo A Koyfman, Phuc F Nguyen-Tân, Sue S Yom, Francis S Cardinale, Khalil Sultanem and 5 more

Abstract readClinical Trial, Phase IIClinical Trial, Phase IIIMulticenter Study
In one paragraph

Trial report in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 13 institutions in 2 countries.

Gwen WyattCollege of Nursing, Michigan State University, 1355 Bogue St. Room C345, East Lansing, MI, 48824, USA. Gwen.Wyatt@hc.msu.edu.
Stephanie L PughNRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA.
Raimond K W WongJuravinski Cancer Centre, Hamilton, ON, Canada.
Stephen SagarJuravinski Cancer Centre, Hamilton, ON, Canada.
Anurag K SinghRoswell Park Cancer Institute, Buffalo, NY, USA.
Shlomo A KoyfmanCleveland Clinic, Cleveland, OH, USA.
Phuc F Nguyen-TânCentre Hospitalier de l'Université de Montréal-Hôpital Notre-Dame, Montreal, QC, Canada.
Sue S YomUniversity of California San Francisco, San Francisco, CA, USA.
Francis S CardinaleYale-New Haven Hospital Saint Raphael Campus, New Haven, CT, USA.
Khalil SultanemMcGill University, Montreal, QC, Canada.
Ian HodsonJuravinski Cancer Centre, Hamilton, ON, Canada.
Greg A KremplUniversity of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Barbara LukaszczykJohn H. Stroger, Jr. Hospital of Cook County MB-CCOP, Chicago, IL, USA.
Alexander M YehIndiana University Hospital/Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.
Lawrence BerkUniversity of South Florida H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Juravinski Cancer Centre · CACleveland Clinic · USHôpital Notre-Dame · CAIndiana University Health · USJohn H. Stroger, Jr. Hospital of Cook County · USMcGill University · CAMichigan State University · USMoffitt Cancer Center · USNRG Oncology · USRoswell Park Comprehensive Cancer Center · USUniversity of California, San Francisco · USUniversity of Oklahoma Health Sciences Center · USYale New Haven Hospital · US

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
RTOG Foreign AccrualU10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI CURRAN, WALTER J. · 1985 to 2013
$150.3M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI James J. Dignam, GREG YOTHERS · 2014 to 2026
$146.4M
NRG Oncology NCORP Research Base-BIQSFPUG1CA189867 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Deborah Watkins Bruner, Lisa A. Kachnic · 2014 to 2026
$140.5M
RTOG Foreign AccrualsU10CA037422 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI BRUNER, DEBORAH WATKINS · 1985 to 2013
$30.4M
Stroger Hospital of Cook County (SHCC) NCORPUG1CA190000 · NCI · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI Deimante Tamkus · 2014 to 2026
$11.1M
NCI NIH HHS U10 CA021661NCI NIH HHS U10 CA037422NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS UG1 CA189867NCI NIH HHS UG1 CA190000
6 · The paper itself

Abstract

purposeThe purpose of this secondary analysis was to determine change in overall health-related quality of life (HRQOL) based on patient data obtained from NRG Oncology RTOG 0537 as measured by the RTOG-modified University of Washington Head and Neck Symptom Score (RM-UWHNSS).

methodsA multi-site prospective randomized clinical trial design stratified 137 patients with post-radiation therapy xerostomia according to prior pilocarpine (PC) treatment and time after radiation therapy and/or chemotherapy and randomized patients into two groups. Patients were assigned to acupuncture or PC. Twenty-four sessions of acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) were administered over 12 weeks, or oral PC (5 mg) three times daily over the same 12 weeks. The RM-UWHNSS was administered at baseline and at 4, 6, 9, and 15 months after the date of randomization.

resultsThere were no between-arm differences in change scores on the RM-UWHNSS in the individual items, total score, or factor scores. For statistical modeling, race and time were significant for all outcomes (total and factor scores), while treatment arm was not significant. The ALTENS arm showed greater yet nonsignificant improvement in outcomes compared to the PC arm.

conclusionAlthough no significant treatment differences were seen in this trial, patients receiving ALTENS consistently had lower scores, indicating better function, as compared to those receiving PC. Radiation-induced xerostomia improved over time for all patients.

Indexed as

Sickness Impact ProfileAdultAgedFemaleHead and Neck NeoplasmsHumansMaleMedical OncologyMiddle AgedProspective StudiesTranscutaneous Electric Nerve StimulationXerostomiaAcupuncture-like transcutaneous electrical nerve stimulation (ALTENS)Head and neck cancerRadiation-induced xerostomia (RIX)Symptom management

Identifiers

PMID26914104
PMCPMC4982852
OpenAlexW2276901416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.